Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.
about
3,4-methylenedioxymethamphetamine (MDMA): current perspectivesEcstasy use and depression: a 4-year longitudinal study among an Australian general community sample.Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice.(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.'Ecstasy' and the use of sleep medications in a general community sample: a 4-year follow-up.Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study.
P2860
Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Single oral doses of (±) 3,4-m ...... and metabolite concentrations.
@en
Single oral doses of (±) 3,4-m ...... and metabolite concentrations.
@nl
type
label
Single oral doses of (±) 3,4-m ...... and metabolite concentrations.
@en
Single oral doses of (±) 3,4-m ...... and metabolite concentrations.
@nl
prefLabel
Single oral doses of (±) 3,4-m ...... and metabolite concentrations.
@en
Single oral doses of (±) 3,4-m ...... and metabolite concentrations.
@nl
P2093
P2860
P1476
Single oral doses of (±) 3,4-m ...... and metabolite concentrations.
@en
P2093
George A Ricaurte
George Hatzidimitriou
Melanie Mueller
Una D McCann
P2860
P304
P356
10.1017/S1461145712000582
P577
2012-07-24T00:00:00Z